ID   GALM_HUMAN              Reviewed;         342 AA.
AC   Q96C23; Q53RY1; Q8NIA2; V9HWA8;
DT   10-MAY-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   15-MAR-2017, entry version 136.
DE   RecName: Full=Aldose 1-epimerase;
DE            EC=5.1.3.3;
DE   AltName: Full=Galactose mutarotase;
GN   Name=GALM; ORFNames=BLOCK25;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Gorry M.C., Zhang Y., Marks J.J., Suppes B., Hart P.S., Cortelli J.R.,
RA   Pallos D., Hart T.C.;
RT   "Physical/genetic map of the 2p22-2p21 region on chromosome 2.";
RL   Submitted (NOV-2001) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Li J.Y., Wang H.Y., Liu F.J., Liu J.;
RL   Submitted (JUN-2008) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Ovary;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   FUNCTION, AND MUTAGENESIS OF HIS-107; HIS-176 AND GLU-307.
RX   PubMed=12753898; DOI=10.1016/S0014-5793(03)00364-8;
RA   Timson D.J., Reece R.J.;
RT   "Identification and characterisation of human aldose 1-epimerase.";
RL   FEBS Lett. 543:21-24(2003).
RN   [8]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-14, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) IN COMPLEX WITH SUBSTRATE, AND
RP   FUNCTION.
RX   PubMed=15026423; DOI=10.1074/jbc.M402347200;
RA   Thoden J.B., Timson D.J., Reece R.J., Holden H.M.;
RT   "Molecular structure of human galactose mutarotase.";
RL   J. Biol. Chem. 279:23431-23437(2004).
CC   -!- FUNCTION: Mutarotase converts alpha-aldose to the beta-anomer. It
CC       is active on D-glucose, L-arabinose, D-xylose, D-galactose,
CC       maltose and lactose (By similarity). {ECO:0000250,
CC       ECO:0000269|PubMed:12753898, ECO:0000269|PubMed:15026423}.
CC   -!- CATALYTIC ACTIVITY: Alpha-D-glucose = beta-D-glucose.
CC       {ECO:0000255|PROSITE-ProRule:PRU10126}.
CC   -!- PATHWAY: Carbohydrate metabolism; hexose metabolism.
CC   -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:15026423}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the aldose epimerase family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAL62475.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY064382; AAL62475.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AY064381; AAL62475.1; JOINED; Genomic_DNA.
DR   EMBL; AY064379; AAL62475.1; JOINED; Genomic_DNA.
DR   EMBL; AY064380; AAL62475.1; JOINED; Genomic_DNA.
DR   EMBL; AY064378; AAL62475.1; JOINED; Genomic_DNA.
DR   EMBL; AY064385; AAL62476.1; -; Genomic_DNA.
DR   EMBL; AY064378; AAL62476.1; JOINED; Genomic_DNA.
DR   EMBL; AY064380; AAL62476.1; JOINED; Genomic_DNA.
DR   EMBL; AY064379; AAL62476.1; JOINED; Genomic_DNA.
DR   EMBL; AY064381; AAL62476.1; JOINED; Genomic_DNA.
DR   EMBL; AY064384; AAL62476.1; JOINED; Genomic_DNA.
DR   EMBL; AY064383; AAL62476.1; JOINED; Genomic_DNA.
DR   EMBL; EU794611; ACJ13665.1; -; mRNA.
DR   EMBL; AK291489; BAF84178.1; -; mRNA.
DR   EMBL; AC074366; AAX93101.1; -; Genomic_DNA.
DR   EMBL; CH471053; EAX00367.1; -; Genomic_DNA.
DR   EMBL; BC014916; AAH14916.1; -; mRNA.
DR   EMBL; BC019263; AAH19263.1; -; mRNA.
DR   CCDS; CCDS1797.1; -.
DR   RefSeq; NP_620156.1; NM_138801.2.
DR   RefSeq; XP_011530842.1; XM_011532540.1.
DR   UniGene; Hs.435012; -.
DR   PDB; 1SNZ; X-ray; 2.20 A; A/B=1-342.
DR   PDB; 1SO0; X-ray; 2.30 A; A/B/C/D=1-342.
DR   PDBsum; 1SNZ; -.
DR   PDBsum; 1SO0; -.
DR   ProteinModelPortal; Q96C23; -.
DR   SMR; Q96C23; -.
DR   BioGrid; 126244; 5.
DR   IntAct; Q96C23; 1.
DR   MINT; MINT-5001489; -.
DR   STRING; 9606.ENSP00000272252; -.
DR   iPTMnet; Q96C23; -.
DR   PhosphoSitePlus; Q96C23; -.
DR   BioMuta; GALM; -.
DR   DMDM; 67463772; -.
DR   EPD; Q96C23; -.
DR   MaxQB; Q96C23; -.
DR   PaxDb; Q96C23; -.
DR   PeptideAtlas; Q96C23; -.
DR   PRIDE; Q96C23; -.
DR   Ensembl; ENST00000272252; ENSP00000272252; ENSG00000143891.
DR   GeneID; 130589; -.
DR   KEGG; hsa:130589; -.
DR   UCSC; uc002rqy.4; human.
DR   CTD; 130589; -.
DR   DisGeNET; 130589; -.
DR   GeneCards; GALM; -.
DR   HGNC; HGNC:24063; GALM.
DR   HPA; HPA035472; -.
DR   HPA; HPA035473; -.
DR   MIM; 137030; gene.
DR   neXtProt; NX_Q96C23; -.
DR   OpenTargets; ENSG00000143891; -.
DR   PharmGKB; PA134980075; -.
DR   eggNOG; KOG1604; Eukaryota.
DR   eggNOG; COG2017; LUCA.
DR   GeneTree; ENSGT00510000047589; -.
DR   HOGENOM; HOG000072798; -.
DR   HOVERGEN; HBG051697; -.
DR   InParanoid; Q96C23; -.
DR   KO; K01785; -.
DR   OMA; SPNHPDW; -.
DR   OrthoDB; EOG091G0COE; -.
DR   PhylomeDB; Q96C23; -.
DR   TreeFam; TF324207; -.
DR   BioCyc; MetaCyc:HS07125-MONOMER; -.
DR   BRENDA; 5.1.3.3; 2681.
DR   SABIO-RK; Q96C23; -.
DR   SignaLink; Q96C23; -.
DR   UniPathway; UPA00242; -.
DR   ChiTaRS; GALM; human.
DR   EvolutionaryTrace; Q96C23; -.
DR   GeneWiki; Galactose_mutarotase; -.
DR   GenomeRNAi; 130589; -.
DR   PRO; PR:Q96C23; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000143891; -.
DR   CleanEx; HS_GALM; -.
DR   ExpressionAtlas; Q96C23; baseline and differential.
DR   Genevisible; Q96C23; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0004034; F:aldose 1-epimerase activity; IDA:UniProtKB.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:InterPro.
DR   GO; GO:0033499; P:galactose catabolic process via UDP-galactose; IBA:GO_Central.
DR   GO; GO:0006012; P:galactose metabolic process; IDA:UniProtKB.
DR   GO; GO:0006006; P:glucose metabolic process; IDA:UniProtKB.
DR   Gene3D; 2.70.98.10; -; 1.
DR   InterPro; IPR018052; Ald1_epimerase_CS.
DR   InterPro; IPR015443; Aldose_1-epimerase.
DR   InterPro; IPR008183; Aldose_1/G6P_1-epimerase.
DR   InterPro; IPR011013; Gal_mutarotase_SF_dom.
DR   InterPro; IPR014718; GH-type_carb-bd.
DR   Pfam; PF01263; Aldose_epim; 1.
DR   PIRSF; PIRSF005096; GALM; 1.
DR   SUPFAM; SSF74650; SSF74650; 1.
DR   PROSITE; PS00545; ALDOSE_1_EPIMERASE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Carbohydrate metabolism; Complete proteome;
KW   Cytoplasm; Isomerase; Phosphoprotein; Polymorphism;
KW   Reference proteome.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330}.
FT   CHAIN         2    342       Aldose 1-epimerase.
FT                                /FTId=PRO_0000197433.
FT   REGION       81     82       Substrate binding.
FT   ACT_SITE    176    176       Proton donor.
FT   ACT_SITE    307    307       Proton acceptor.
FT   BINDING     243    243       Substrate. {ECO:0000269|PubMed:15026423}.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:19413330}.
FT   MOD_RES      14     14       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     124    124       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q66HG4}.
FT   VARIANT     190    190       N -> Y (in dbSNP:rs6741892).
FT                                /FTId=VAR_024451.
FT   MUTAGEN     107    107       H->A: Reduces activity over 5-fold.
FT                                {ECO:0000269|PubMed:12753898}.
FT   MUTAGEN     176    176       H->A: Loss of activity.
FT                                {ECO:0000269|PubMed:12753898}.
FT   MUTAGEN     307    307       E->A: Loss of activity.
FT                                {ECO:0000269|PubMed:12753898}.
FT   STRAND        3     12       {ECO:0000244|PDB:1SNZ}.
FT   TURN         13     16       {ECO:0000244|PDB:1SNZ}.
FT   STRAND       17     25       {ECO:0000244|PDB:1SNZ}.
FT   STRAND       30     34       {ECO:0000244|PDB:1SNZ}.
FT   STRAND       39     46       {ECO:0000244|PDB:1SNZ}.
FT   STRAND       52     54       {ECO:0000244|PDB:1SNZ}.
FT   HELIX        62     66       {ECO:0000244|PDB:1SNZ}.
FT   STRAND       81     83       {ECO:0000244|PDB:1SNZ}.
FT   HELIX        84     86       {ECO:0000244|PDB:1SNZ}.
FT   STRAND       87     90       {ECO:0000244|PDB:1SNZ}.
FT   STRAND       93     96       {ECO:0000244|PDB:1SNZ}.
FT   STRAND      104    106       {ECO:0000244|PDB:1SNZ}.
FT   STRAND      109    111       {ECO:0000244|PDB:1SNZ}.
FT   HELIX       113    115       {ECO:0000244|PDB:1SNZ}.
FT   STRAND      119    123       {ECO:0000244|PDB:1SNZ}.
FT   STRAND      126    133       {ECO:0000244|PDB:1SNZ}.
FT   HELIX       137    139       {ECO:0000244|PDB:1SNZ}.
FT   STRAND      144    153       {ECO:0000244|PDB:1SNZ}.
FT   STRAND      156    167       {ECO:0000244|PDB:1SNZ}.
FT   STRAND      193    196       {ECO:0000244|PDB:1SNZ}.
FT   STRAND      198    201       {ECO:0000244|PDB:1SNZ}.
FT   HELIX       230    236       {ECO:0000244|PDB:1SNZ}.
FT   STRAND      243    248       {ECO:0000244|PDB:1SNZ}.
FT   STRAND      251    253       {ECO:0000244|PDB:1SO0}.
FT   STRAND      255    261       {ECO:0000244|PDB:1SNZ}.
FT   TURN        263    265       {ECO:0000244|PDB:1SNZ}.
FT   STRAND      267    281       {ECO:0000244|PDB:1SNZ}.
FT   STRAND      287    291       {ECO:0000244|PDB:1SNZ}.
FT   HELIX       293    295       {ECO:0000244|PDB:1SNZ}.
FT   STRAND      297    299       {ECO:0000244|PDB:1SNZ}.
FT   STRAND      304    310       {ECO:0000244|PDB:1SNZ}.
FT   HELIX       314    316       {ECO:0000244|PDB:1SNZ}.
FT   STRAND      331    341       {ECO:0000244|PDB:1SNZ}.
SQ   SEQUENCE   342 AA;  37766 MW;  611A54AE7E85813E CRC64;
     MASVTRAVFG ELPSGGGTVE KFQLQSDLLR VDIISWGCTI TALEVKDRQG RASDVVLGFA
     ELEGYLQKQP YFGAVIGRVA NRIAKGTFKV DGKEYHLAIN KEPNSLHGGV RGFDKVLWTP
     RVLSNGVQFS RISPDGEEGY PGELKVWVTY TLDGGELIVN YRAQASQATP VNLTNHSYFN
     LAGQASPNIN DHEVTIEADT YLPVDETLIP TGEVAPVQGT AFDLRKPVEL GKHLQDFHLN
     GFDHNFCLKG SKEKHFCARV HHAASGRVLE VYTTQPGVQF YTGNFLDGTL KGKNGAVYPK
     HSGFCLETQN WPDAVNQPRF PPVLLRPGEE YDHTTWFKFS VA
//
